HOME >> BIOLOGY >> NEWS
Columbia University awards 2006 Horwitz Prize to biologist who explained gene transcription

New York, NY October 4, 2006 Columbia University will award the 2006 Louisa Gross Horwitz Prize to structural biologist Roger D. Kornberg, Ph.D., Winzer Professor in Medicine at the Stanford School of Medicine. Dr. Kornberg will be honored for his work revolutionizing our understanding of gene transcription, the first step in transforming the genomic code in the cell into proteins, which run the cell.

It was also announced today that Dr. Kornberg has won the 2006 Nobel Prize in Chemistry.

"Dr. Kornberg's research is fundamental in pointing the way to innovative therapies for cancer, heart disease and other illnesses in which there is disturbance of genetic activity," said Lee Goldman, M.D., executive vice president of Columbia University and dean of the faculties of health sciences and medicine at Columbia University Medical Center. "His work represents exactly the type of scientific activity that we are proud to honor with the Horwitz Prize."

"We are pleased to continue our Horwitz tradition by awarding this year's prize to Roger Kornberg," said David Hirsh, Ph.D., executive vice president for research at Columbia University. "His groundbreaking work has been central to explaining the fundamental basis of gene regulation."

The Louisa Gross Horwitz Prize was established by Columbia University to recognize outstanding contributions to basic research in the fields of biology and biochemistry. Awarded annually since 1967, the prize was named for the mother of Columbia benefactor S. Gross Horwitz. Louisa Gross Horwitz was daughter of Dr. Samuel David Gross, author of "A System of Surgery" and a founder of the American Medical Association. For additional information about the Louisa Gross Horwitz Prize, visit: http://www.cumc.columbia.edu/horwitz.

"I'm pleased to receive this prestigious recognition, and am delighted to share the honor with some of the most distingu
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
4-Oct-2006


Page: 1 2 3

Related biology news :

1. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
2. Columbia scientists determine 3-dimensional structure of cells fuel gauge
3. Columbia University licenses next-generation DNA sequencing technology
4. New bird discovered on unexplored Columbian mountain
5. Columbia University Medical Center receives major new NIH Clinical Science investment funds
6. Columbia University receives $16.9 million NIEHS award to study arsenic in ground water
7. Contaminants linked to sturgeon decline in Columbia river
8. Columbia University Medical Center researchers discover potential mechanism for tumor growth
9. UF, Columbia scientists closer to new cancer detection method
10. Columbia University awards 2005 Horwitz Prize to Israeli structural biologist
11. Columbia wins major grant to examine genetic link to Alzheimers Disease

Post Your Comments:
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
(Date:2/27/2015)... FamilyFarms Group is pleased to announce its ... Farms, received the 2015 Tomorrow’s Top Producer Horizon Award. ... of 35, who has demonstrated excellence in the business ... the Tomorrow's Top Producer Horizon Award. Every year I ... Award and learning from their experiences. It is truly ...
(Date:2/27/2015)... Feb. 27, 2015  Steep Hill, the industry leader ... internationally, intends to open a full service medical cannabis ... , bringing advanced scientific tools and methodology to ... Steep Hill is currently the only laboratory licensed by ... and contaminant testing in order to meet the recently ...
(Date:2/26/2015)... Feb. 26, 2015 S&P Capital IQ (MHFI) ... Report coverage on MabVax Therapeutics Holdings Inc . ... clinical stage biotechnology company focused on the development of ... in the treatment of cancer. MabVax has discovered a ... protective immune responses generated by patients who have been ...
(Date:2/26/2015)... VIEW, Calif. , Feb. 26, 2015  23andMe, ... of Kate Black as Privacy Officer and ... federal, and state privacy laws as well as health ... regulatory team, she will be responsible for reviewing, updating ... customers in the U.S. and abroad. She joined the ...
Breaking Biology Technology:Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
Cached News: